Reuters | The World's Leading Provider of Financial Information and News Substance in Saliva Protects Babies from Mom's HIV
October 29, 2002 02:16 PM ET
Email this article Printer friendly version Purchase for Reprint
?
By Alison McCook
NEW YORK (Reuters Health) - Babies with relatively high levels of a particular compound in their saliva appear to be less likely than others to acquire HIV from their infected mothers at one month of age, according to new study findings.
Dr. Carey Farquhar of the University of Washington in Seattle and colleagues found that babies with higher levels of a substance called secretory leukocyte protease inhibitor (SLPI) at one month of age were half as likely as those with lower levels of SLPI to have acquired HIV from
Tuesday, October 29, 2002
Documents Show Effort to Promote Unproven Drug New York Times, Oct 29, 2002
By MELODY PETERSEN
Marketing executives at Warner-Lambert urged their superiors to let them promote the epilepsy drug Neurontin for an unapproved use rather than perform the clinical studies needed to prove the medicine was safe for such patients, according to a corporate memorandum unsealed on Friday in federal court. [ This article gives detail into marketing techniques used by drug company Warner-Lambert to push drug on physicians and patients. - JC]
By MELODY PETERSEN
Marketing executives at Warner-Lambert urged their superiors to let them promote the epilepsy drug Neurontin for an unapproved use rather than perform the clinical studies needed to prove the medicine was safe for such patients, according to a corporate memorandum unsealed on Friday in federal court. [ This article gives detail into marketing techniques used by drug company Warner-Lambert to push drug on physicians and patients. - JC]
Subscribe to:
Posts (Atom)